These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19774844)

  • 21. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist.
    Hagen CP; Sørensen K; Anderson RA; Juul A
    Fertil Steril; 2012 Nov; 98(5):1326-30. PubMed ID: 22901847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty.
    Mul D; de Muinck Keizer-Schrama SM; Oostdijk W; Drop SL
    Horm Res; 1999 Dec; 51(6):270-6. PubMed ID: 10640887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
    Li WJ; Gong CX; Guo MJ; Xing J; Li T; Song WH; Luo XP; Wu D; Liang JP; Cao BY; Gu Y; Su C; Liang XJ; Liu M; Wang R; Li FT
    Chin Med J (Engl); 2015 May; 128(10):1314-20. PubMed ID: 25963350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.
    Adan L; Chemaitilly W; Trivin C; Brauner R
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):297-302. PubMed ID: 11940040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
    Vurallı D; Alikaşifoğlu A; İyigün İ; Canoruç D; Ozon A; Gönç N; Kandemir N
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):37-44. PubMed ID: 31347350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome.
    Spielmann S; Partsch CJ; Gosch A; Pankau R
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1363-7. PubMed ID: 26197460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone.
    Vottero A; Pedori S; Verna M; Pagano B; Cappa M; Loche S; Bernasconi S; Ghizzoni L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1284-7. PubMed ID: 16449342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin and Estradiol Levels after Leuprolide Stimulation Tests in Brazilian Girls with Precocious Puberty.
    Junqueira FR; Lara LA; Martins WP; Ferriani RA; Rosa-E-Silva AC; de Sá MF; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):313-6. PubMed ID: 26094907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty.
    Acharya SV; Gopal RA; George J; Bandgar TR; Menon PS; Shah NS
    Pituitary; 2009; 12(4):335-8. PubMed ID: 19396631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty.
    Kobayashi Y; Murata A; Yasuda T; Minagawa M; Wataki K; Ohnishi H; Niimi H
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):351-5. PubMed ID: 8187298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.
    Tanaka T; Hibi I; Kato K; Saito S; Shimizu N; Suwa S; Nakajima H
    Endocrinol Jpn; 1991 Aug; 38(4):369-76. PubMed ID: 1839379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results.
    Mericq V; Lammoglia JJ; Unanue N; Villaroel C; Hernández MI; Avila A; Iñiguez G; Klein KO
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):686-90. PubMed ID: 19302581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty.
    Fuld K; Chi C; Neely EK
    J Pediatr; 2011 Dec; 159(6):982-7.e1. PubMed ID: 21798557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.
    Badaru A; Wilson DM; Bachrach LK; Fechner P; Gandrud LM; Durham E; Wintergerst K; Chi C; Klein KO; Neely EK
    J Clin Endocrinol Metab; 2006 May; 91(5):1862-7. PubMed ID: 16449344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog.
    Maffeis C; Franceschi R; Moghetti P; Camilot M; Lauriola S; Tatò L
    Eur J Endocrinol; 2007 Jan; 156(1):99-103. PubMed ID: 17218731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.